Skip to main content

ITCI

Stock
Health Care
Drug Manufacturers - Specialty & Generic

Performance overview

ITCI Price
Price Chart

Forward-looking statistics

Beta
1.18
Risk
54.06%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.

Company info

SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
Employees537
Market cap$7.2B

Fundamentals

Enterprise value
Revenue
Revenue per employee
Profit margin
Debt to equity

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)
Dividend per share
Revenue per share
Avg trading volume (30 day)
Avg trading volume (10 day)
Put-call ratio

Macro factor sensitivity

Growth+1.5
Credit+4.9
Liquidity+0.8
Inflation-3.6
Commodities-0.9
Interest Rates-2.5

Valuation

Dividend yield0.00%
PEG Ratio
Price to sales
P/E Ratio507.19
Enterprise Value to Revenue
Price to book

Upcoming events

Next earnings day
Next dividend day
Ex. dividend day

News

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales

Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven by strong Caplyta sales.

Zacks Investment Research (February 24, 2025)
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by 'David and Goliath dynamic' in 2024, report says.

CNBC (January 21, 2025)
Top 4 Health Care Stocks You May Want To Dump In Q1

As of Jan. 21, 2025, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga (January 21, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free